// App-Quantinova.ai

4907 : Epigenetic treatment of ovarian cancer cells increases immune cell recruitment to the tumor microenvironment: implications for response to immune checkpoint therapy

Researchers

Presenter

  • Meredith L. Stone

Principal Investigators

  • Katherine B. Chiappinelli

  • Huili Li

  • Lauren Murphy

  • Michael Topper

  • Stephen Baylin

  • Cynthia Zahnow

Medical Centers

  • Johns Hopkins University School of Medicine, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High-grade serous carcinoma

  • Gynaecological cancer

  • Solid malignancies

  • High grade serous ovarian cancer

Biomarkers

  • Cluster of differentiation 69

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • Vidaza

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved